Form 4 · Filed Jul 1, 2026, 11:30 PM UTC
AXSM/Axsome Therapeutics, Inc.
TABUTEAU HERRIOT — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | M | other | 49,666 | $5 | $245,847 | 56,895 |
| Jul 1, 2026 | S | sell | 49,666 | $240 | $11,932,257 | 7,229 |
| Jul 1, 2026 | M | other | 49,666 | — | — | 49,664 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-292985